This project will continue to focus on the identification of environmental and genetic risk factors for development of hepatocellular carcinoma (HCC) in Taiwan. We have demonstrated that, in conjunction with hepatitis B or C virus (HBV and HCV) infection, aflatoxin B1 (AFB1), 4-aminobiphenyl, and polycyclic aromatic hydrocarbons (PAH), increase HCC risk. Synergistic interactions between virus and chemical were also observed. Deletion o glutathione S-transferase M1(GSTM1) further increased risk in exposed subjects. The current proposal will focus on a case-control study nested in a cohort established by our collaborator Dr. Chien Jen Chen in which 25,611 subjects were recruited and a total of approximately 350 HCC cases will be identified by the end of the next four years. We will analyze blood samples from cases and controls for urinary aflatoxin metabolites and AFB1- and PAH-albumin adducts as markers of exposure. We will also begin to investigate the role of oxidative stress in risk for HCC by analyzing for variants in genes that encode enzymes with pro-oxidant and anti-oxidant activities. damage from ROS and carcinogenic metabolites that are not detoxified may be prevented from contributing to carcinogenesis by DNA repair; thus, we will extend our investigation of genetic susceptibility to DNA repair genes in the base excision and nucleotide excision repair pathways. We hypothesize that cases will more frequently be carriers of """"""""higher risk"""""""" alleles than controls and that there will also be an interaction between environmental exposures and genotype. Finally, we will carry out a small exploratory study to determine whether tumor DNA can be detected in plasma of HCC cases. Other studies have demonstrated that tumor DNA circulating in blood contains the same genetic alterations as are found in the tumor. We will begin to investigate this phenomena in our HCC cases specifically looking at p.53 mutations and methylation of p16. These pilot studies will allow us to determine whether tumor DNA can be found at a high enough frequency to be useful in diagnosis and studies of etiology, when in the cancer process they are detectable.

Agency
National Institute of Health (NIH)
Institute
National Institute of Environmental Health Sciences (NIEHS)
Type
Research Project (R01)
Project #
5R01ES005116-12
Application #
6518058
Study Section
Special Emphasis Panel (ZRG1-SNEM-1 (05))
Program Officer
Gray, Kimberly A
Project Start
1990-01-01
Project End
2005-06-30
Budget Start
2002-08-12
Budget End
2003-06-30
Support Year
12
Fiscal Year
2002
Total Cost
$367,875
Indirect Cost
Name
Columbia University (N.Y.)
Department
Public Health & Prev Medicine
Type
Schools of Public Health
DUNS #
167204994
City
New York
State
NY
Country
United States
Zip Code
10032
Chu, Yu-Ju; Yang, Hwai-I; Wu, Hui-Chen et al. (2018) Aflatoxin B1 exposure increases the risk of hepatocellular carcinoma associated with hepatitis C virus infection or alcohol consumption. Eur J Cancer 94:37-46
Chu, Yu-Ju; Yang, Hwai-I; Wu, Hui-Chen et al. (2017) Aflatoxin B1 exposure increases the risk of cirrhosis and hepatocellular carcinoma in chronic hepatitis B virus carriers. Int J Cancer 141:711-720
Yeh, Chih-Ching; Goyal, Abhishek; Shen, Jing et al. (2017) Global Level of Plasma DNA Methylation is Associated with Overall Survival in Patients with Hepatocellular Carcinoma. Ann Surg Oncol 24:3788-3795
Zeng, Hui; Wu, Hui-Chen; Wang, Qiao et al. (2017) Telomere Length and Risk of Hepatocellular Carcinoma: A Nested Case-control Study in Taiwan Cancer Screening Program Cohort. Anticancer Res 37:637-644
Wu, Hui-Chen; Yang, Hwai-I; Wang, Qiao et al. (2017) Plasma DNA methylation marker and hepatocellular carcinoma risk prediction model for the general population. Carcinogenesis 38:1021-1028
Shen, Jing; Wang, Qiao; Gurvich, Irina et al. (2016) Evaluating normalization approaches for the better identification of aberrant microRNAs associated with hepatocellular carcinoma. Hepatoma Res 2:305-315
Wu, Hui-Chen; Shen, Jing; Yang, Hwai-I et al. (2016) Blood DNA methylation markers in prospectively identified hepatocellular carcinoma cases and controls from Taiwan. World J Hepatol 8:301-6
Shen, Jing; Siegel, Abby B; Remotti, Helen et al. (2016) Identifying microRNA panels specifically associated with hepatocellular carcinoma and its different etiologies. Hepatoma Res 2:151-162
Ruan, Peifeng; Shen, Jing; Santella, Regina M et al. (2016) NEpiC: a network-assisted algorithm for epigenetic studies using mean and variance combined signals. Nucleic Acids Res 44:e134
Shen, Jing; Yeh, Chih-Ching; Wang, Qiao et al. (2016) Plasma Adiponectin and Hepatocellular Carcinoma Survival Among Patients Without Liver Transplantation. Anticancer Res 36:5307-5314

Showing the most recent 10 out of 48 publications